TECX

29.99

2.99% 0.87

Handel nachbörslich: 30.75 0.76 +2.53%

Tectonic Therapeutic Inc (TECX)

Überblick Nachrichten Preisverlauf Forum Prognose

Schlusskurs vom Vortag:

$29.12

Offen:

$30.92

24-Stunden-Volumen:

367.35K

Relative Volume:

1.42

Marktkapitalisierung:

$565.89M

Einnahmen:

Nettoeinkommen (Verlust:

$-74.15M

KGV:

-7.4212

EPS:

-4.0411

Netto-Cashflow:

$-60.29M

1W Leistung:

+9.89%

1M Leistung:

+5.08%

6M Leistung:

+40.21%

1J Leistung:

+38.52%

1-Tages-Spanne:

$29.34

$32.26

1-Wochen-Bereich:

$27.10

$32.26

52-Wochen-Spanne:

$14.38

$36.03

Tectonic Therapeutic Inc Stock (TECX) Company Profile

Firmenname

Tectonic Therapeutic Inc

Sektor

Healthcare (1111)

Branche

Biotechnology (621)

Telefon

(339) 666-3320

Adresse

490 ARSENAL WAY, WATERTOWN

Mitarbeiter

Twitter

Nächster Verdiensttermin

2026-05-14

Neueste SEC-Einreichungen

TECX's Discussions on Twitter

Compare TECX vs VRTX, REGN, ARGX, ALNY, RVMD

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
TECX Tectonic Therapeutic Inc	29.99	549.47M	0	-74.15M	-60.29M	-4.0411
VRTX Vertex Pharmaceuticals Inc	435.93	110.28B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	634.62	66.98B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	808.43	50.15B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	295.50	39.71B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	154.89	32.22B	742.00K	-1.37B	-1.07B	-7.0731

Tectonic Therapeutic Inc Stock (TECX) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2026-04-14	Eingeleitet	Stifel	Buy
2025-10-20	Eingeleitet	Wells Fargo	Overweight
2025-09-03	Eingeleitet	Oppenheimer	Outperform
2025-07-21	Eingeleitet	Truist	Buy
2025-06-11	Fortgesetzt	Raymond James	Outperform
2025-04-21	Eingeleitet	Mizuho	Outperform
2024-11-20	Eingeleitet	Raymond James	Outperform
2024-08-22	Eingeleitet	Wells Fargo	Overweight
2024-06-26	Eingeleitet	Piper Sandler	Overweight
2024-06-24	Eingeleitet	TD Cowen	Buy
2023-12-18	Herabstufung	Mizuho	Buy → Neutral
2022-01-05	Herabstufung	BTIG Research	Buy → Neutral
2021-11-19	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2021-06-15	Eingeleitet	BTIG Research	Buy
2021-05-27	Eingeleitet	Needham	Buy
2021-03-09	Eingeleitet	Barclays	Overweight
2021-03-02	Eingeleitet	Stifel	Hold
2020-11-11	Eingeleitet	Berenberg	Buy
2020-03-31	Herabstufung	H.C. Wainwright	Buy → Neutral
2019-06-27	Eingeleitet	Mizuho	Buy
2019-04-05	Eingeleitet	Janney	Buy
2018-10-10	Eingeleitet	Guggenheim	Buy
2018-10-02	Bestätigt	H.C. Wainwright	Buy
2018-09-17	Eingeleitet	H.C. Wainwright	Buy
2018-07-16	Eingeleitet	Wedbush	Outperform
2018-07-16	Eingeleitet	Wells Fargo	Outperform

Alle ansehen

Tectonic Therapeutic Inc Aktie (TECX) Neueste Nachrichten

05:09 AM

Raymond James upgrades Tectonic Therapeutics stock rating on pipeline potential - Investing.com Australia

05:09 AM

May 22, 2026

Tectonic Therapeutic (TECX) Edges Lower as Support Levels Come into FocusSocial Trading Insights - Newser

May 22, 2026

May 21, 2026

Tectonic Therapeutic (TECX) Slips Slightly as Stock Holds Above Key SupportLeveraged ETF Flow - Newser

May 21, 2026

May 20, 2026

Tectonic Therapeutic (TECX) Q1 2026 Results Fall Short — EPS $-1.34, Revenue $N/AGuidance vs Actual - Newser

May 20, 2026

May 19, 2026

Tectonic Therapeutics: Currently In A Catalyst Vacuum (NASDAQ:TECX) - Seeking Alpha

May 19, 2026

May 16, 2026

LifeSci Capital Maintains Tectonic Therapeutic(TECX.US) With Buy Rating, Maintains Target Price $88 - Moomoo

May 16, 2026

Number of shareholders of Tectonic Therapeutic, Inc. – NASDAQ:TECX - TradingView

May 16, 2026

May 15, 2026

Tectonic Therapeutic Gains 11%, Insider Trades Reap Benefit - simplywall.st

May 15, 2026

May 11, 2026

Truist Financial Maintains Tectonic Therapeutic(TECX.US) With Buy Rating, Announces Target Price $60 - 富途牛牛

May 11, 2026

Wells Fargo Maintains Tectonic Therapeutic(TECX.US) With Buy Rating, Maintains Target Price $101 - Moomoo

May 11, 2026

MSN Money - MSN

May 11, 2026

May 10, 2026